Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties

Ben Lan Lin; Xiao Dong Shen; Sheng Cui

doi:10.1088/1748-6041/2/2/011

Application of nanosized Fe₃O₄ in anticancer drug carriers with target-orientation and sustained-release properties

Ben Lan Lin, Xiao Dong Shen, Sheng Cui

Nanjing University of Aeronautics and Astronautics

Research output: Contribution to journal › Article › peer-review

67 Scopus citations

Abstract

The purpose of this study was to prepare human serum albumin (HSA) microspheres with Fe₃O₄ magnetic nanoparticles for tumor target therapy. Fe₃O₄ was obtained by liquid-phase coprecipitation; HSA-coated magnetic particles were attained by solidification at high temperature. The result was that nanosized Fe₃O₄ is a cubic crystal by XRD and the average size is 18.7 nm; the average size of HSA-coated magnetic particles is 341 nm. Fe₃O₄ magnetic nanoparticles coated with HSA can be used for targeted-drug carriers with target-orientation and sustained-release properties.

Original language	English
Article number	011
Pages (from-to)	132-134
Number of pages	3
Journal	Biomedical Materials (Bristol)
Volume	2
Issue number	2
DOIs	https://doi.org/10.1088/1748-6041/2/2/011
State	Published - 1 Jun 2007
Externally published	Yes

Access to Document

10.1088/1748-6041/2/2/011

Cite this

@article{cb32bfd308294d3cb60a761a3276c01b,

title = "Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties",

abstract = "The purpose of this study was to prepare human serum albumin (HSA) microspheres with Fe3O4 magnetic nanoparticles for tumor target therapy. Fe3O4 was obtained by liquid-phase coprecipitation; HSA-coated magnetic particles were attained by solidification at high temperature. The result was that nanosized Fe3O4 is a cubic crystal by XRD and the average size is 18.7 nm; the average size of HSA-coated magnetic particles is 341 nm. Fe3O4 magnetic nanoparticles coated with HSA can be used for targeted-drug carriers with target-orientation and sustained-release properties.",

author = "Lin, {Ben Lan} and Shen, {Xiao Dong} and Sheng Cui",

year = "2007",

month = jun,

day = "1",

doi = "10.1088/1748-6041/2/2/011",

language = "英语",

volume = "2",

pages = "132--134",

journal = "Biomedical Materials (Bristol)",

issn = "1748-6041",

publisher = "IOP Publishing Ltd.",

number = "2",

}

TY - JOUR

T1 - Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties

AU - Lin, Ben Lan

AU - Shen, Xiao Dong

AU - Cui, Sheng

PY - 2007/6/1

Y1 - 2007/6/1

N2 - The purpose of this study was to prepare human serum albumin (HSA) microspheres with Fe3O4 magnetic nanoparticles for tumor target therapy. Fe3O4 was obtained by liquid-phase coprecipitation; HSA-coated magnetic particles were attained by solidification at high temperature. The result was that nanosized Fe3O4 is a cubic crystal by XRD and the average size is 18.7 nm; the average size of HSA-coated magnetic particles is 341 nm. Fe3O4 magnetic nanoparticles coated with HSA can be used for targeted-drug carriers with target-orientation and sustained-release properties.

AB - The purpose of this study was to prepare human serum albumin (HSA) microspheres with Fe3O4 magnetic nanoparticles for tumor target therapy. Fe3O4 was obtained by liquid-phase coprecipitation; HSA-coated magnetic particles were attained by solidification at high temperature. The result was that nanosized Fe3O4 is a cubic crystal by XRD and the average size is 18.7 nm; the average size of HSA-coated magnetic particles is 341 nm. Fe3O4 magnetic nanoparticles coated with HSA can be used for targeted-drug carriers with target-orientation and sustained-release properties.

UR - http://www.scopus.com/inward/record.url?scp=34249032144&partnerID=8YFLogxK

U2 - 10.1088/1748-6041/2/2/011

DO - 10.1088/1748-6041/2/2/011

M3 - 文章

C2 - 18458446

AN - SCOPUS:34249032144

SN - 1748-6041

VL - 2

SP - 132

EP - 134

JO - Biomedical Materials (Bristol)

JF - Biomedical Materials (Bristol)

IS - 2

M1 - 011

ER -

Application of nanosized Fe₃O₄ in anticancer drug carriers with target-orientation and sustained-release properties

Abstract

Access to Document

Other files and links

Fingerprint

Cite this